ClinicalTrials.Veeva

Menu

Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)

Imperial College London logo

Imperial College London

Status

Completed

Conditions

Type 1 Diabetes

Treatments

Device: ABC4D
Device: Standard bolus calculator

Study type

Interventional

Funder types

Other

Identifiers

NCT02053051
13SM0091

Details and patient eligibility

About

This study aims to assess the safety and efficacy of a novel advanced bolus calculator in subjects with Type 1 diabetes. Insulin bolus calculators have been developed to aid insulin dose adjustment and existing standard insulin bolus calculator consist of a simple algorithm that requires five subject-specific parameters as input to generate a recommended bolus insulin dose:

  • current blood glucose (mmol/L)
  • target blood glucose (mmol/L)
  • insulin-to-carbohydrate ratio (grams of carbohydrate per 1 unit of insulin)
  • total grams of carbohydrate in meals
  • insulin sensitivity factor (reduction in glucose per 1 unit of insulin)

Full description

The Diabetes Technology team at Imperial College have developed a novel advanced bolus calculator. The complete integrated system consists of a commercially available smartphone that holds the novel advanced algorithm. The system requires regular updates of cases derived from retrospective blinded continuous glucose monitoring data and for this a commercially available glucose sensor will be used. Each new case includes information about the problem (e.g. capillary blood glucose, meal information and physical exercise), solution (recommended insulin dose) and outcome (blood glucose following a meal). The novel decision support algorithm is based on case-based reasoning (CBR). CBR is an artificial intelligence technique that tries to solve newly encountered problems by applying the solutions learned from solved problems encountered in the past.

The end-product is therefore a subject specific insulin bolus calculator that continues to improve with time. The project utilises commercially available glucose sensors and smartphones (iPhone), integrated with a novel algorithm for insulin bolus calculation. The aim of the ABC4D is to minimise high and low glucose excursions which are associated with the complications of diabetes including blindness, kidney failure, nerve damage and cardiovascular disease.

An interim analysis was conducted in Phase 4 after 25 participants completed the study (in line with the protocol) and it was agreed to stop the study at this stage. A further protocol amendment was approved by REC/MHRA to commence ABC4D phase 5 (different CT.gov number: NCT03963219).

Enrollment

25 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ≥18 years of age
  • Diagnosis of T1DM for > 1 year
  • On MDI using a basal-bolus insulin regime
  • Structured education in previous 3 years
  • HbA1c ≤ 86mmol/mol
  • No severe hypoglycaemia (defined as needing 3rd party assistance) in previous year

Exclusion criteria

  • Recurrent severe hypoglycaemia
  • Pregnant or planning pregnancy
  • Breastfeeding
  • Enrolled in other clinical trials
  • Have active malignancy or under investigation for malignancy
  • Addison's Disease
  • Gastroparesis
  • Autonomic neuropathy
  • Concomitant use of GLP-1 analogues and gliptins
  • Visual impairment
  • Reduced manual dexterity

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Phase 4: Intervention (ABC4D)
Experimental group
Description:
Advanced Bolus Calculator for Type Diabetes (ABC4D)
Treatment:
Device: ABC4D
Phase 4 Control: Standard bolus calculator
Active Comparator group
Description:
Standard bolus calculator
Treatment:
Device: Standard bolus calculator

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems